Yardena R. Samuels

Person

Rehovot, IL

People

Patents Grantslast 30 patents

Information Patent Grant
Combination therapy for the treatment of cancer
- Patent number 11,471,504
- Issue date Oct 18, 2022
- Yeda Research and Development Co. Ltd.
- Yardena Samuels
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
GRM3 mutations and use thereof for the diagnosis and treatment of m...
- Patent number 8,795,964
- Issue date Aug 5, 2014
- The United States of America, as represented by the Secretary, Department of...
- Yardena R. Samuels
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
T CELL RECEPTORS DIRECTED AGAINST RAS-DERIVED RECURRENT NEOANTIGENS...
- Publication number 20240180966
- Publication date Jun 6, 2024
- Yeda Research and Development Co. Ltd.
- Yardena SAMUELS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TUMOR IMMUNITY INDUCES THE PRESENTATION OF ABERRANT PEPTIDES
- Publication number 20230390371
- Publication date Dec 7, 2023
- Stichting het Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis
- Reuven AGAMI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IDENTIFICATION OF RECURRENT MUTATED NEOPEPTIDES
- Publication number 20220241331
- Publication date Aug 4, 2022
- Yeda Research and Development Co. Ltd.
- Yardena SAMUELS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINATION WITH CANCER NEOANTIGENS
- Publication number 20210315983
- Publication date Oct 14, 2021
- Yeda Research and Development Co. Ltd.
- Yardena SAMUELS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR THE TREATMENT OF CANCER
- Publication number 20210154261
- Publication date May 27, 2021
- Yeda Research and Development Co. Ltd.
- Yardena SAMUELS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ERBB4 AS A PROGNOSTIC AND THERAPEUTIC MARKER FOR MELANOMA
- Publication number 20140141431
- Publication date May 22, 2014
- The United States of America, as represented by the Secretary, Department of...
- Yardena R. Samuels
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Yardena R. Samuels

Person

Patents Grantslast 30 patents

Combination therapy for the treatment of cancer

GRM3 mutations and use thereof for the diagnosis and treatment of m...

Patents Applicationslast 30 patents

T CELL RECEPTORS DIRECTED AGAINST RAS-DERIVED RECURRENT NEOANTIGENS...

ANTI-TUMOR IMMUNITY INDUCES THE PRESENTATION OF ABERRANT PEPTIDES

IDENTIFICATION OF RECURRENT MUTATED NEOPEPTIDES

VACCINATION WITH CANCER NEOANTIGENS

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

USE OF ERBB4 AS A PROGNOSTIC AND THERAPEUTIC MARKER FOR MELANOMA